focus
Previous article:
Psychedelics group wrestles with new pharma identity
Next article: EpiPen alternative approval delay highlights citizen petition issue
Next article: EpiPen alternative approval delay highlights citizen petition issue
focus
hotspot
-
Maui wildfire now ranks as the fifth
2025-10-02 20:21 -
Drug for rare kidney disease narrowly misses mark in clinical trial
2025-10-02 20:11 -
CDC's new outbreak response network to include Northeastern
2025-10-02 20:09 -
Bird flu researchers hone in on Finland’s mink farms
2025-10-02 19:26 -
Novo Nordisk touts Wegovy study, but still struggling with supply
2025-10-02 19:03 -
Indictment alleges Trump's ex
2025-10-02 18:37